The c-MYC NHE III(1): function and regulation

Annual Review of Pharmacology and Toxicology
Verónica González, Laurence H Hurley

Abstract

c-MYC is an important regulator of a wide array of cellular processes necessary for normal cell growth and differentiation, and its dysregulation is one of the hallmarks of many cancers. Consequently, understanding c-MYC transcriptional activation is critical for understanding developmental and cancer biology, as well as for the development of new anticancer drugs. The nuclease hypersensitive element (NHE) III(1) region of the c-MYC promoter has been shown to be particularly important in regulating c-MYC expression. Specifically, the formation of a G-quadruplex structure appears to promote repression of c-MYC transcription. This review focuses on what is known about the formation of a G-quadruplex in the NHE III(1) region of the c-MYC promoter, as well as on those factors that are known to modulate its formation. Last, we discuss the development of small molecules that stabilize or induce the formation of G-quadruplex structures and could potentially be used as anticancer agents.

References

Jan 1, 1992·Annual Review of Biochemistry·K B MarcuA J Patel
Jan 1, 1991·Advances in Cancer Research·C A Spencer, M Groudine
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·I A MastrangeloP V Hough
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·T L DavisA J Kinniburgh
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L F Liu, J C Wang
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·P D FahrlanderG Klein
Jan 1, 1987·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·K B Marcu
Jan 1, 1985·Annual Review of Biophysics and Biophysical Chemistry·C J Benham
Apr 20, 1984·Science·D J SlamonM J Cline
Sep 22, 1995·Journal of Molecular Biology·J S LeeD G Scraba
Apr 21, 1995·The Journal of Biological Chemistry·E F MichelottiD Levens
May 1, 1996·Molecular and Cellular Biology·E F MichelottiD Levens
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·T Tomonaga, D Levens
Jan 1, 1996·Advances in Cancer Research·J M LemaitreM Méchali
Feb 17, 1997·FEBS Letters·K BomsztykJ Ostrowski
Sep 5, 1997·The Journal of Biological Chemistry·E F MichelottiD Levens
Apr 4, 1998·Nucleic Acids Research·T SimonssonM Kubista
Apr 29, 1998·Annual Review of Physiology·E B Thompson
Dec 16, 1998·Trends in Biochemical Sciences·A Ostareck-LedererM W Hentze
Dec 22, 1998·Molecular and Cellular Biology·C V Dang
Jun 23, 1999·Oncogene·C E NesbitE V Prochownik
Nov 26, 1999·Gene·G Suske
Feb 19, 2000·Current Opinion in Genetics & Development·S PelengarisT Littlewood
Oct 14, 2000·Annual Review of Cell and Developmental Biology·C GrandoriR N Eisenman
Nov 10, 2000·Biochemical and Biophysical Research Communications·T SimonssonM Vorlickova
Dec 31, 2000·The Journal of Biological Chemistry·M MandalR Kumar
Jan 9, 2001·Trends in Cell Biology·E H PapK W Wirtz
Feb 27, 2001·FEBS Letters·S NasiL Soucek
Jun 5, 2001·Nature Cell Biology·M ChiarielloJ S Gutkind
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·C SchaffitzelA Plückthun

❮ Previous
Next ❯

Citations

Dec 24, 2013·European Journal of Medicinal Chemistry·Mads Corvinius NielsenTrond Ulven
Jul 20, 2013·Journal of Medicinal Chemistry·Rosalba PerroneSara N Richter
Apr 2, 2011·Nature Reviews. Drug Discovery·Shankar BalasubramanianStephen Neidle
Oct 4, 2012·Nature Reviews. Genetics·Matthew L BochmanVirginia A Zakian
Mar 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·Adelene Y TanJames L Manley
Sep 23, 2010·The Journal of Biological Chemistry·Luca FedericiMaurizio Brunori
May 20, 2011·Nucleic Acids Research·Mykola I OnyshchenkoIgor G Panyutin
Mar 1, 2012·Nucleic Acids Research·John M NicoludisLiliya A Yatsunyk
Nov 21, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nihar Ranjan, Dev P Arya
Oct 11, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joanna BidzinskaMarco Folini
Oct 25, 2013·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tarek ShalabyMichael Grotzer
Nov 23, 2011·European Journal of Medicinal Chemistry·Zeng LiZhi-Shu Huang
Mar 25, 2011·Biochemical Society Transactions·Robert V Brown, Laurence H Hurley
Dec 25, 2012·Biochemical and Biophysical Research Communications·Jing LinZhi-shu Huang
Feb 26, 2015·Biochemical and Biophysical Research Communications·Saptaparni Ghosh, Dipak Dasgupta
Nov 14, 2016·Biochimica Et Biophysica Acta. General Subjects·Manuela PorruAnnamaria Biroccio
Feb 6, 2014·The FEBS Journal·Navin C SabharwalLiliya A Yatsunyk
Dec 31, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Roberta RoccaLucia Parrotta
Mar 11, 2016·Organic & Biomolecular Chemistry·Ajay ChauhanJyotirmayee Dash
Nov 13, 2014·Chemical Communications : Chem Comm·Jin-Qiang HouZhi-Shu Huang
Mar 19, 2011·Chemistry : a European Journal·Hélène BertrandMarie-Paule Teulade-Fichou
Nov 2, 2014·ChemMedChem·K V DiveshkumarP I Pradeepkumar
Feb 26, 2013·Protein Science : a Publication of the Protein Society·Luca Federici, Brunangelo Falini

❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear magnetic resonance

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.